Obtaining an NMPA registration certificate for EEG machines in China involves fulfilling several regulatory requirements, including clinical trials where applicable. Here's a detailed overview of the key requirements:

1. Device Classification

• Classification: Determine the classification of your EEG machine according to Chinese medical device regulations (Class I, II, or III). Higher-risk devices (Class II and III) typically require more stringent regulatory requirements, including clinical evaluations or trials.

2. Technical Documentation Requirements

• Technical Documentation: Prepare comprehensive technical documentation, including:
  • Device description and specifications.
  • Design drawings and manufacturing information.
  • Risk management documentation (ISO 14971).
  • Quality management system (QMS) documentation (GB/T 19001-2016).
  • Testing and evaluation reports (electrical safety, EMC, performance testing).

3. Clinical Evaluation Requirements

• Clinical Evaluation: Conduct a clinical evaluation to demonstrate the safety, efficacy, and performance of the EEG machine. Clinical evaluation may include:
  • Literature Review: Summarize existing clinical data and literature supporting the safety and performance of similar devices.
  • Clinical Data Collection: Collect clinical data from studies, trials, or post-market surveillance.
  • Clinical Evaluation Report (CER): Prepare a detailed report summarizing the clinical evaluation findings and conclusions.

4. Clinical Trials (if required)

• Clinical Trials: For higher-risk devices (Class II and III), NMPA may require clinical trials to provide additional evidence of safety and efficacy. Key considerations include:
  • Study Design: Define the study objectives, methodology, patient population, and endpoints in a clinical trial protocol.
  • Ethical Approval: Obtain approval from ethics committees or institutional review boards (IRBs) for the clinical trial protocol and informed consent procedures.
  • Data Collection: Collect clinical data according to the protocol, ensuring compliance with good clinical practice (GCP) guidelines.
  • Data Analysis: Analyze clinical trial data to assess safety and effectiveness outcomes.
  • Reporting: Prepare clinical trial reports and submit them as part of the regulatory submission.

5. Quality Management System (QMS)

• QMS Requirements: Implement and maintain a quality management system that complies with GB/T 19001-2016 (ISO 9001:2015 equivalent). The QMS should ensure consistent quality in the design, manufacturing, and distribution of the EEG machine.

6. Testing and Verification

• Testing Requirements: Conduct testing to verify compliance with relevant technical standards, including:
  • Electrical safety (e.g., IEC 60601-1).
  • Electromagnetic compatibility (EMC) (e.g., IEC 60601-1-2).
  • Performance testing to validate accuracy, reliability, and operational characteristics.

7. Labeling and Instructions for Use (IFU)

• Labeling: Ensure labeling of the EEG machine complies with NMPA regulations, including device identification, manufacturer information, intended use, warnings, and instructions for use (IFU) in Chinese.

8. Post-Market Surveillance

• Post-Market Surveillance: Implement a post-market surveillance system to monitor the safety and performance of the EEG machine after it enters the market. Report any adverse events or incidents to NMPA as required.

9. Authorized Representative (if applicable)

• Authorized Representative: If your company is based outside China, appoint an authorized representative within China responsible for regulatory compliance and communication with NMPA.

10. Application and Submission

• Application Process: Compile all required documentation and submit the application for NMPA registration through the designated online platform or submission channels. Ensure all documentation is complete, accurate, and meets NMPA requirements.

Contact Us：

Whatsapp or Wechat：+86 15816864648；email address：hito.lin@grzan.cn